COMMUNIQUÉS West-GlobeNewswire

Diversicare Announces 2017 Fourth Quarter Results

01/03/2018 - 22:05

BRENTWOOD, Tenn., March 01, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR ), a premier provider of long-term care services, today announced its results for the fourth quarter ended [...]

OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results

01/03/2018 - 22:05

MIAMI, March 01, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK ) reports business highlights and financial results for the three months ended December 31, 2017. Business Highlights RAYALDEE total prescriptions [...]

Cidara Announces Appointment of Chrysa Mineo as Independent Director

01/03/2018 - 22:05

SAN DIEGO, March 01, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX ), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the appointment of Chrysa [...]

Quotient Limited to Participate in the Cowen 38th Annual Global Health Care Conference

01/03/2018 - 22:05

JERSEY, Channel Islands, March 01, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT ), a commercial-stage diagnostics company, today announced that the Company's Chairman and Chief Executive Officer, Paul Cowan, [...]

Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

01/03/2018 - 22:05

MENLO PARK, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Versartis, Inc . (NASDAQ: VSAR ), an endocrine-focused biopharmaceutical company, today announced financial results for the fourth quarter and full year ended [...]

Radius Health Reports Fourth Quarter and Full Year 2017 Financial and Operating Results and Provides Business Update

01/03/2018 - 22:01

TYMLOS ™ sales show accelerating market share growth, capturing approximately 32% of osteoporosis patients new to anabolic therapy Abaloparatide patch program advances with FDA alignment on regulatory pathway and [...]

Apricus Biosciences Provides Corporate Update, Fourth Quarter and Full Year 2017 Financial Results

01/03/2018 - 22:01

Company Expects to Submit Vitaros End of Review Meeting Request This Month Vitaros End-of-Review Meeting Expected to Occur in April 2018 Company Expects Cash Runway Through 2018 Conference Call / Webcast Today, March 1 [...]

Aduro Biotech Announces Fourth Quarter and Full Year 2017 Financial Results

01/03/2018 - 22:01

BERKELEY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO ) today reported financial results for the year ended December 31, 2017. Net loss for the fourth quarter and year ended December 31 [...]

Sarepta Therapeutics Announces Fourth Quarter 2017 and Full-Year 2017 Financial Results and Recent Corporate Developments

01/03/2018 - 22:01

-- Fourth quarter 2017 EXONDYS 51® (eteplirsen) total net revenues of $57.3 million -- -- Cash and investment balance of $1.1 billion as of December 31, 2017 -- CAMBRIDGE, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- [...]

Tetraphase Pharmaceuticals Appoints Larry Edwards Chief Operating Officer

01/03/2018 - 22:01

WATERTOWN, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]

Harvard Bioscience Reports Fourth Quarter and Year-End 2017 Results

01/03/2018 - 22:01

HOLLISTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO ) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, [...]

NewLink Genetics Reports Fourth Quarter, Year-End 2017 Financial Results and Provides Update for Indoximod Programs

01/03/2018 - 22:01

AMES, Iowa, March 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today reported consolidated financial results for the fourth quarter and year ended 2017, as well as progress in its clinical [...]

Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

01/03/2018 - 22:01

BOSTON, March 01, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP ), a biotechnology company focused on development of next generation immunotherapies utilizing gene- and cell-based therapies to treat [...]

MannKind Opens Enrollment of Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension

01/03/2018 - 22:01

WESTLAKE VILLAGE, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD ), focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as [...]

Nkarta Therapeutics Appoints Veteran Executive Paul Hastings as CEO to Lead Next Phase of Growth

01/03/2018 - 20:05

SOUTH SAN FRANCISCO, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Nkarta Therapeutics, a privately-held cell therapy company developing natural killer (NK) immune cells to fight cancer, announced that it has named [...]

UPDATE - FibroGen Granted Fast Track Designation by U.S. FDA for Pamrevlumab Treatment of Patients with Locally Advanced Unresectable Pancreatic Cancer

01/03/2018 - 19:45

SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a science-based biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track [...]

Evolent Health CEO Frank Williams Joins Syapse Board of Directors

01/03/2018 - 19:43

SAN FRANCISCO, March 01, 2018 (GLOBE NEWSWIRE) -- Syapse, a leading precision medicine company, announced today that Frank Williams, the co-founder and CEO of Evolent Health, has joined the company’s board of directors [...]

Orion Corporation: Transfer of 112,961 own B shares on 1 March 2018

01/03/2018 - 18:11

ORION CORPORATION STOCK EXCHANGE RELEASE 1 MARCH 2018 at 19.10 EET Orion Corporation: Transfer of 112,961 own B shares on 1 March 2018 In accordance with a decision by the Board of Directors, Orion Corporation has on 1 [...]

CROSSJECT : Financial calendar 2018

01/03/2018 - 18:00

Press release Crossject announces its financial calendar 2018 Dijon, 1st March 2018 CROSSJECT (ISIN: FR0011716265; Ticker: ALCJ), a specialty pharma company developing a portfolio of innovative combined drugs for use in [...]